Mind Medicine MindMed Inc. buy Royal Bank of Canada
Start price
05.06.24
/
50%
€6.61
Target price
05.06.25
€20.24
Performance (%)
10.22%
Price
19.07.24
€7.28
Summary
This prediction is currently active. The prediction currently has a performance of 10.22%. This prediction currently runs until 05.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mind Medicine MindMed Inc. | 6.511% | 6.511% |
iShares Core DAX® | -3.033% | -0.013% |
iShares Nasdaq 100 | -3.554% | -2.546% |
iShares Nikkei 225® | -3.938% | 2.183% |
iShares S&P 500 | -1.517% | -0.882% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Mind Medicine MindMed Inc. diskutieren
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $22.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Mind Medicine MindMed Inc.
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€5.23
29.02.24
29.02.24
€13.89
28.02.25
28.02.25
39.33%
19.07.24
19.07.24
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€2.50
23.10.23
23.10.23
€6.57
23.10.24
23.10.24
191.20%
19.07.24
19.07.24
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€3.95
04.08.23
04.08.23
€6.34
04.08.24
04.08.24
84.40%
19.07.24
19.07.24
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€2.84
13.03.23
13.03.23
€4.66
13.03.24
13.03.24
193.66%
14.03.24
14.03.24